A phase I trial of PR-104, a nitrogen mustard prodrug...

Cancer Chemotherapy and Pharmacology 2010 / 03 Vol. 65; Iss. 4

A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors

Michael B. Jameson, Danny Rischin, Mark Pegram, John Gutheil, Adam V. Patterson, William A. Denny, William R. Wilson
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
65
Language:
english
Pages:
11
DOI:
10.1007/s00280-009-1188-1
Date:
March, 2010
File:
PDF, 303 KB
english, 2010
Conversion to is in progress
Conversion to is failed